Diabetic Peripheral Neuropathy

Sponsored by North American Center for Continuing Medical Education, LLC

Authors

Peter Sheehan, MD
Mt. Sinai School of Medicine
New York, New York

Allen Jacobs, DPM, FAPWCA, FACFAS
Private Practice
St. Louis, Missouri

Target Audience

This activity is designed for vascular surgeons, endocrinologists, podiatrists, nurses, primary care physicians, wound care specialists and diabetic educators.

Learning Objectives

After completing this activity, participants should be able to:

• describe new concepts in the pathogenesis of diabetic peripheral neuropathy
• explain the role of endothelial dysfunction and how it can be manipulated
• demonstrate the remittive qualities of L-Methylfolate, pyridoxal-5-phosphate and methylcobalamin
• discuss theoretical maintenance “neural steady-state”
• review the role of homocystine in the ideology of diabetic neuropathy
• review the pharmacological agents for reduction of homocystine level

Activity Overview

This accredited monograph is available in PDF format.

To be eligible for documentation of credit, participants must read all monograph content, complete 20-question post-test with a score of 70% or better, and complete the evaluation form on-line. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.

There is no fee associated with this activity.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release Date: 4-1-09

Expiration Date: 4-1-10  

Estimated time to complete: 1 hour

CME Accreditation

This activity is sponsored by the North American Center for Continuing Medical Education (NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies.

CPME Accreditation

NACCME is approved by the Council on Podiatric Medical Education as a sponsor of continuing education in podiatric medicine. This program is approved for 1 continuing education contact hour.

CNE Accreditation

NACCME is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 1 contact hour. Provider #: 110-3-E-06. Provider approved by the California Board of Registered Nursing, Provider Number 13255 for 1contact hour.

AHRA Accreditation

Approved by American Healthcare Radiology Administrators for 1Category A, ARRT continuing education credit.

Independent Clinical Reviewer

Robert S. Dieter, MD, R.V.T.
Loyola University Medical Center
Vascular and Endovascular Medicine
Interventional Cardiology 
Assistant Professor of Medicine
Section of Cardiovascular Medicine
Maywood, Illinois

Planning Committee

The planning committee comprises Peter Sheehan, MD, Allen Jacobs, DPM, FAPWCA, FACFAS; Robert Dieter, MD, RVT.; Trish Levy and Alex Slonim, NACCME

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity.  All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest.  If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
                
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:
Dr. Sheehan has disclosed that he has received grant/research support from Tissue Repair Company, PamLab, Genzyme and Sanofi-Aventis. He is the Director of Greystone Pharmaceuticals. He is a member of the scientific advisory board for Advanced BioHealing. He is a Consultant for Heal Or, Hypermed and Calretex. He is a member of the speakers bureau for BMS/Sanofi, Merck and Organogenesis.

Dr. Jacobs has disclosed that he is a member of the speakers bureau for Pamlab, Inc.

Dr. Dieter has disclosed that he has no relevant financial relationships with any organization that could be perceived as a conflict of interest.

A. Slonim and T. Levy, NACCME have disclosed that they have no significant financial relationship with any commercial interest.

Off-Label/Unapproved Usage

ACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed the following off-label/unapproved use(s) of drugs and/or devices will be discussed: The use of pharmacologic agents for the treatment of peripheral neuropathy.

Grant Support

Supported by an educational grant from PamLabs